Lycopene for the prevention and treatment of prostate disease

Recent Results in Cancer Research

Volumn 202, Issue , 2014, Pages 109-114

  Ilic, Dragan ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LYCOPENE; PROSTATE SPECIFIC ANTIGEN;

CANCER PREVENTION; CANCER THERAPY; DIET THERAPY; DIETARY INTAKE; DRUG EFFICACY; HUMAN; LIFESTYLE MODIFICATION; LOWER URINARY TRACT SYMPTOM; MEDICATION THERAPY MANAGEMENT; NUTRITIONAL VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; REVIEW; ANTIOXIDANT ACTIVITY; DIET SUPPLEMENTATION; EVIDENCE BASED MEDICINE; FRUIT; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SYSTEMATIC REVIEW (TOPIC); VEGETABLE;

ANTIOXIDANTS; CAROTENOIDS; HUMANS; MALE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 84958549179     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-45195-9_13     Document Type: Review

References (26)

1. Ansari M, Gupta N (2003) A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU Int 92: 375-378
2. Bailey R, Gahche J, Lenito C et al (2011) Dietary supplement use in the United States, 2003-2006. J Nutr 141: 261-266
3. Berry S, Coffey D, Walsh P, Ewing L (1984) The development of human benign prostatic hyperplasia with age. J Urol 132: 474-479
4. Chan J, Gann P, Giovannucci E (2005) Role of diet in prostate cancer development and progression. J Clin Oncol 23: 8152-8160
5. Coyne K, Sexton C, Thompson C et al (2009) The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 104: 352-360
6. Dennert G, Zwahlen M, Brinkman M, Vinceti M, Zeegers M, Horneber M (2011) Selenium for preventing cancer. Cochrane Database Syst Rev. Issue 5. Art. no.: CD005195. doi:005110.001002/14651858.CD14005195.pub14651852
7. Etminan M, Takkouche B, Caamano-Isorna F (2004) The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomark Prev 13: 340-345
8. Haseen F, Cantwell M, O'Sullivan J, Murray L (2009) Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review. Prostate Cancer Prostatic Dis 12: 325-332
9. Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU Guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59: 61-71
10. Hoffman R, MacDonald R, Wilt T. Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev. Issue 1. Art. no.: CD001987. doi:10.1002/14651858.CD001987.pub2
11. Ilic D, Misso M (2012) Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review. Maturitas 72: 269-276
12. Ilic D, Forbes K, Hassad C (2011) Lycopene for the prevention of prostate cancer. Cochrane Database Syst Rev. Issue 11. Art. no.: CD008007. doi:10.1002/14651858.CD008007.pub2)
13. Ilic D, Neuberger M, Djulbegovic M, Dahm P (2013) Screening for prostate cancer. Cochrane Database Syst Rev. Issue 1. Art. no.: CD004720. doi:004710.001002/14651858.CD14004720.pub14651853
14. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90
15. Karas M, Amir H, Fishman D et al (2000) Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 26: 101-111
16. Matsushima N, Shidoji Y, Nishiwaki S, Yamada T, Moriwaki H, Muto Y (1995) Suppression by carotenoids of microcystin-induced morphological changes in mouse hepatocytes. Lipids 30: 1029-1034
17. McVary K, Roehrborn C, Avins A et al (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185: 1793-1803
18. Porrini M, Riso P (2005) What are typical lycopene intakes? J Nutr 135: 2042S-2045S
19. Schwarz S, Obermuller-Jevic U, Hellmis E, Koch W, Jacobi G, Biesalski H (2008) Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J Nutr 138: 49-53
20. Stratton J, Godwin M (2011) The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis. Fam Pract 28: 243-252
21. Tacklind J, Fink H, MacDonald R, Rutks I, Wilt T (2010) Finasteride for benign prostatic hyperplasia. Cochrane Database Syst Rev. Issue 10. Art. no.: CD006015. doi:10.1002/14651858.CD006015.pub3
22. Wang X (2012) Lycopene metabolism and its biological significance. Am J Clin Nutr 96: 1214S-1222S
23. Wertz K, Siler U, Goralczyk R (2004) Lycopene: modes of action to promote prostate health. Arch Biochem Biophys 430: 127-134
24. Wilt T, Ishani A (1998) Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev. Issue 1. Art. no.: CD001044. doi:10.1002/14651858.CD001044
25. Wilt T, MacDonald R, Hagerty K, Schellhammer P, Kramer B (2008) 5-alpha-reductase inhibitors for prostate cancer prevention. Cochrane Database of Systematic Reviews.;Issue 2. Art. no.: CD007091. DOI:10.1002/14651858. CD007091
26. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: A global perspective. AICR, Washington D.C.